SCHEDULE: American Century Discloses 4.3% Stake in Timken Co.

American Century Investment Management, Inc., along with its parent entities, reported a beneficial ownership of 4.3% of The Timken Company's common stock as of December 31, 2025.

Summary

• American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research collectively beneficially own 2,974,175 shares of The Timken Company's common stock.
• This ownership represents 4.3% of the total class of securities.
• The reporting persons hold sole voting power over 2,874,333 shares and sole dispositive power over 2,974,175 shares.
• The securities were acquired and are held in the ordinary course of business, without the purpose or effect of changing or influencing the control of The Timken Company.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral filing, primarily a compliance update on beneficial ownership. It reflects a stable, passive institutional investment without indicating any significant operational or strategic changes for The Timken Company.

Future Outlook

NA

Management Comments

• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures by institutional investors holding significant, but passive, stakes in public companies. American Century's 4.3% stake in The Timken Company, a global manufacturer of bearings and power transmission products, indicates a continued investment interest in the industrial sector, aligning with broader trends of institutional capital allocation towards established industrial players.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's passive stake, confirming no intent to influence control.

Key Dates

Keywords

The Timken Company, American Century Investment Management, American Century Companies, Stowers Institute for Medical Research, Common Stock, Beneficial Ownership, Schedule 13G, Institutional Investor, Equity Stake